文献速递肝病消化内镜

糖尿病是经颈静脉肝内门体分流术后肝性脑病的危险因素

Diabetes Mellitus is a Risk Factor for Hepatic Encephalopathy Following Transjugular Intrahepatic Portosystemic Shunt.
PubMed 文献 · Aliment Pharmacol Ther · 2025-11-28

这项回顾性队列研究纳入2007至2021年接受TIPS的325例肝硬化患者,其中34.8%合并糖尿病。多变量Cox竞争风险分析显示,糖尿病独立关联肝性脑病(aHR 1.56)和重度肝性脑病(aHR 1.76)风险。

要点

  • TIPS术后6个月肝性脑病累积发生率45.2%,重度肝性脑病25.1%。
  • 糖尿病是TIPS术后肝性脑病和重度肝性脑病的独立危险因素。
  • 该关联独立于年龄和MELD-Na评分。

核心结论

  • TIPS术后肝性脑病发生率高,糖尿病是其显著且独立的危险因素。

研究设计与样本

  • 回顾性队列研究,纳入2007至2021年接受TIPS的肝硬化患者325例,113例(34.8%)合并糖尿病。

主要发现

  • 6个月肝性脑病累积发生率为45.2%(95% CI 39.5-51.8)。
  • 6个月重度肝性脑病累积发生率为25.1%(95% CI 20.2-31.3)。
  • 多变量Cox竞争风险分析:糖尿病与肝性脑病风险独立关联(aHR 1.56,95% CI 1.08-2.26,p=0.018)。
  • 糖尿病与重度肝性脑病风险独立关联(aHR 1.76,95% CI 1.07-2.90,p=0.026)。

临床怎么用

  • 对合并糖尿病的肝硬化患者行TIPS术前,应充分评估肝性脑病风险。
  • TIPS术后对合并糖尿病的患者应加强肝性脑病监测。

局限性

  • 回顾性设计。
  • 原文未报告其他局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Transjugular intrahepatic portosystemic shunt (TIPS) placement effectively decreases portal pressure in patients with decompensated cirrhosis. However, many patients develop hepatic encephalopathy (HE) post-TIPS. We investigated the relation between the presence of Diabetes Mellitus (DM) and the occurrence of HE following TIPS placement in patients with cirrhosis. METHODS: In this retrospective cohort study all patients with cirrhosis who received a TIPS from 2007 through 2021 were included. Baseline characteristics and decompensating events including hospital admission for HE were recorded. In cases where hospital admission was required, HE was considered severe. RESULTS: In total, 325 patients were included and 113 (34.8%) had DM at the time of TIPS placement. One hundred and fifty-one patients developed HE of whom 86 (57.0%) were hospitalised. The cumulative 6-month incidences of HE and severe HE were 45.2% (95% CI 39.5-51.8) and 25.1% (95% CI 20.2-31.3), respectively. Multivariable Cox regression with competing risk analyses demonstrated that DM was independently associated with the risk of both HE (aHR 1.56, 95% CI 1.08-2.26, p = 0.018) and severe HE (aHR 1.76, 95% CI 1.07-2.90, p = 0.026). These associations were independent of the relation between HE and age (aHR 1.03, 95% CI 1.01-1.05, p < 0.001) or MELD-Na score (aHR 1.07, 95% CI 1.03-1.10, p < 0.001). CONCLUSIONS: This study highlights the high incidence of HE following TIPS and shows that DM is a significant and independent risk factor for the development of HE. Given the increase in patients with metabolic dysfunction-associated liver cirrhosis and DM, this study offers additional insights into the balance of risks and benefits associated with TIPS placement.

来源:Aliment Pharmacol Ther,查看原文。版权归原作者所有。

引用

  1. Spaan M, Werner E, Dijkstra W, et al. Diabetes Mellitus is a Risk Factor for Hepatic Encephalopathy Following Transjugular Intrahepatic Portosystemic Shunt. Aliment Pharmacol Ther. 2025. PMID: 41315897. doi:10.1111/apt.70453

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。